Result Summary for 104820
|Clinical Study ID:||104820|
|Official Title:||A study to evaluate safety, immunogenicity and efficacy of GSK Biologicals HPV-16/18 L1/AS04 vaccine administered intramuscularly according to a three-dose schedule (0, 1, 6 month) in healthy adult female subjects aged 26 years and above|
|Study Indications or Diseases:||
|Generic Name:||Human Papillomavirus Types 16 and 18 Vaccine|
|Approved Drug Label:||http://www.gsk.com/products.html|
|Results Summary:|| Click
here to download result summary.
The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.